For instance, identifying individuals who have developed resistance to leptin, as a consequence of midlife obesity, may be pertinent as these individuals may be unresponsive to leptin-based therapies. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.